The biological foundations of sarcopenia: established and promising markers

M Casati, AS Costa, D Capitanio, L Ponzoni… - Frontiers in …, 2019 - frontiersin.org
Sarcopenia, the progressive loss of muscle mass and strength, is one of the major health
issues in older adults, given its high prevalence accompanied by huge clinical and …

[HTML][HTML] Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives

Y Rolland, S Czerwinski, GA Van Kan, JE Morley… - The Journal of nutrition …, 2008 - Elsevier
Sarcopenia is a loss of muscle protein mass and loss of muscle function. It occurs with
increasing age, being a major component in the development of frailty. Current knowledge …

Mitochondrial impairment in sarcopenia

F Bellanti, A Lo Buglio, G Vendemiale - Biology, 2021 - mdpi.com
Simple Summary With old age, the strength and size of our muscles worsens with time,
affecting our ability to carry out daily activities. Muscle wasting may be more dangerous for …

Current pharmacotherapies for sarcopenia

JP Hardee, GS Lynch - Expert Opinion on Pharmacotherapy, 2019 - Taylor & Francis
Introduction: Sarcopenia, the age-related loss of skeletal muscle mass and function, is a
global health problem that contributes to the development of physical disability, morbidity …

Sarcopenia: assessment of disease burden and strategies to improve outcomes

I Liguori, G Russo, L Aran, G Bulli, F Curcio… - … interventions in aging, 2018 - Taylor & Francis
Life expectancy is increasing worldwide, with a resultant increase in the elderly population.
Aging is characterized by the progressive loss of skeletal muscle mass and strength–a …

Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy

R Calvani, AM Joseph, PJ Adhihetty, A Miccheli… - Biological …, 2013 - degruyter.com
Muscle loss during aging and disuse is a highly prevalent and disabling condition, but
knowledge about cellular pathways mediating muscle atrophy is still limited. Given the …

Biomarkers in sarcopenia: a multifactorial approach

F Curcio, G Ferro, C Basile, I Liguori, P Parrella… - Experimental …, 2016 - Elsevier
The slow and continuous loss of muscle mass that progresses with aging is defined as
“sarcopenia”. Sarcopenia represents an important public health problem, being closely …

Inflammaging: implications in sarcopenia

E Antuña, C Cachán-Vega, JC Bermejo-Millo… - International journal of …, 2022 - mdpi.com
In a world in which life expectancy is increasing, understanding and promoting healthy
aging becomes a contemporary demand. In the elderly, a sterile, chronic and low-grade …

Sarcopenia: what is the origin of this aging-induced disorder?

T Gustafsson, B Ulfhake - Frontiers in genetics, 2021 - frontiersin.org
We here review the loss of muscle function and mass (sarcopenia) in the framework of
human healthspan and lifespan, and mechanisms involved in aging. The rapidly changing …

The significance of sarcopenia in old age

C Dutta, EC Hadley - The Journals of Gerontology Series A …, 1995 - academic.oup.com
Our knowledge of the significance of sarcopenia in old age is limited by a lack of
epidemiologic data, an incomplete assessment of the pathophysiologic consequences of …